Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 96.34M
March 31, 2026 111.69M
December 31, 2025 126.95M
September 30, 2025 142.36M
June 30, 2025 154.78M
March 31, 2025 169.87M
December 31, 2024 26.82M
September 30, 2024 47.82M
June 30, 2024 68.60M
March 31, 2024 93.20M
December 31, 2023 122.89M
September 30, 2023 152.06M
June 30, 2023 183.11M
March 31, 2023 216.29M
Date Value
December 31, 2022 245.99M
September 30, 2022 279.10M
June 30, 2022 309.76M
March 31, 2022 345.45M
December 31, 2021 374.08M
September 30, 2021 409.75M
June 30, 2021 431.16M
March 31, 2021 306.64M
December 31, 2020 328.61M
September 30, 2020 354.33M
June 30, 2020 118.20M
March 31, 2020 143.93M
December 31, 2019 37.26M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Accuray, Inc. 41.70M
Micron Solutions, Inc. --
Orthofix Medical, Inc. 429.18M
ResMed, Inc. 6.585B
Rockwell Medical, Inc. 35.08M

Shareholders Equity (Quarterly) Related Metrics